Medirom Healthcare Operating Margin vs. Market Capitalization

MRM Stock  USD 1.09  0.03  2.68%   
Based on the measurements of profitability obtained from Medirom Healthcare's financial statements, Medirom Healthcare Technologies is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in January. Profitability indicators assess Medirom Healthcare's ability to earn profits and add value for shareholders.

Medirom Healthcare Operating Profit Margin

(0.0602)

As of the 28th of December 2024, EV To Sales is likely to grow to 1.77, while Price To Sales Ratio is likely to drop 0.58. At this time, Medirom Healthcare's Net Income Per Share is very stable compared to the past year. As of the 28th of December 2024, Net Income Per E B T is likely to grow to 5.86, though Operating Income is likely to grow to (372 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.260.2298
Moderately Up
Slightly volatile
For Medirom Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medirom Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medirom Healthcare Technologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medirom Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medirom Healthcare Technologies over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.582
Earnings Share
(0.15)
Revenue Per Share
1.4 K
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.04)
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medirom Healthcare Market Capitalization vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Medirom Healthcare's current stock value. Our valuation model uses many indicators to compare Medirom Healthcare value to that of its competitors to determine the firm's financial worth.
Medirom Healthcare Technologies is considered to be number one stock in operating margin category among its peers. It also is considered to be number one stock in market capitalization category among its peers . At this time, Medirom Healthcare's Operating Profit Margin is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Medirom Healthcare by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Medirom Market Capitalization vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Medirom Healthcare

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(0.02) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Medirom Healthcare

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
8.81 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Medirom Market Capitalization vs Competition

Medirom Healthcare Technologies is considered to be number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 42.34 Billion. Medirom Healthcare adds roughly 8.81 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Total debt  Valuation  Revenue  Workforce

Medirom Healthcare Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Medirom Healthcare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medirom Healthcare will eventually generate negative long term returns. The profitability progress is the general direction of Medirom Healthcare's change in net profit over the period of time. It can combine multiple indicators of Medirom Healthcare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income-35.8 M-34 M
Interest Income1.1 MM
Operating Income-391.6 M-372 M
Net Income From Continuing Ops115 M120.8 M
Income Before Tax20.6 M21.7 M
Total Other Income Expense Net412.2 M432.8 M
Net Loss-891.7 M-847.1 M
Net Income115 M120.8 M
Income Tax Expense-94.4 M-89.7 M
Change To Netincome351.9 M369.5 M
Net Income Per Share 22.27  23.38 
Income Quality(5.49)(5.22)
Net Income Per E B T 5.58  5.86 

Medirom Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Medirom Healthcare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medirom Healthcare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medirom Healthcare's important profitability drivers and their relationship over time.

Use Medirom Healthcare in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medirom Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medirom Healthcare will appreciate offsetting losses from the drop in the long position's value.

Medirom Healthcare Pair Trading

Medirom Healthcare Technologies Pair Trading Analysis

The ability to find closely correlated positions to Medirom Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medirom Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medirom Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medirom Healthcare Technologies to buy it.
The correlation of Medirom Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medirom Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medirom Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medirom Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Medirom Healthcare position

In addition to having Medirom Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cannabis Thematic Idea Now

Cannabis
Cannabis Theme
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out Correlation Analysis.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
To fully project Medirom Healthcare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Medirom Healthcare at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Medirom Healthcare's income statement, its balance sheet, and the statement of cash flows.
Potential Medirom Healthcare investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Medirom Healthcare investors may work on each financial statement separately, they are all related. The changes in Medirom Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medirom Healthcare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.